Bone turnover in response to 0.25 mg estradiol was similar to that seen with 1.0 mg estradiol. Longer term studies are needed to determine whether the effects on bone turnover seen with 0.25 mg estradiol will translate into increases in bone density and decreases in fractures. Such studies are needed to help the more than 10 million Americans who have osteoporosis, a disease that thins and weakens bones with the most common fractures occurring to the spine, wrist and hip. Some 18 million more have lost enough bone to make them more likely to develop osteoporosis. More than 80 percent of these 28 million people are women.
Osteoporosis is costly both in dollars and in human suffering.
The Bone Thief , with practical information on the prevention and treatment of osteoporosis for the general public. References from this web page or from any of the information services sponsored by FirstGov to any non-governmental entity, product, service or information does not constitute an endorsement or recommendation by FirstGov, Social Security, or any of its employees. Although our page includes links to sites including or referencing good collections of information, we do not endorse any specific products or services provided by public or private organizations.